Cargando…

Understanding the Molecular Basis of 5-HT(4) Receptor Partial Agonists through 3D-QSAR Studies

Alzheimer’s disease (AD) is a neurodegenerative disorder whose prevalence has an incidence in senior citizens. Unfortunately, current pharmacotherapy only offers symptom relief for patients with side effects such as bradycardia, nausea, and vomiting. Therefore, there is a present need to provide oth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castro-Alvarez, Alejandro, Chávez-Ángel, Emigdio, Nelson, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036435/ https://www.ncbi.nlm.nih.gov/pubmed/33808456 http://dx.doi.org/10.3390/ijms22073602

Ejemplares similares

The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor
por: Warne, Tony, et al.
Publicado: (2011)

Anti-PTSD Effects of Hypidone Hydrochloride (YL-0919): A Novel Combined Selective 5-HT Reuptake Inhibitor/5-HT(1A) Receptor Partial Agonist/5-HT(6) Receptor Full Agonist
por: Liu, Wen-Gang, et al.
Publicado: (2021)

Review on Sol-Gel Synthesis of Perovskite and Oxide Nanomaterials
por: Navas, Daniel, et al.
Publicado: (2021)

Chronic Treatment with the 5-HT1A Receptor Partial Agonist Tandospirone Increases Hippocampal Neurogenesis
por: Mori, Masayoshi, et al.
Publicado: (2014)

Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method
por: Wang, Yeng-Tseng, et al.
Publicado: (2017)

A QSAR model of Olanzapine derivatives as potential inhibitors for 5-HT2A Receptor
por: Mitra, Pooja, et al.
Publicado: (2017)

Curated Database and Preliminary AutoML QSAR Model for 5-HT1A Receptor
por: Czub, Natalia, et al.
Publicado: (2021)

Functionalizing Dendrimers for Targeted Delivery of Bioactive Molecules to Macrophages: A Potential Treatment for Mycobacterium tuberculosis Infection—A Review
por: Sanhueza, Claudia, et al.
Publicado: (2023)

Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists Using 3D-QSAR and Molecular Docking
por: Jian, Yaning, et al.
Publicado: (2018)

Metabolic and Cardiovascular Benefits and Risks of EMD386088—A 5-HT(6) Receptor Partial Agonist and Dopamine Transporter Inhibitor
por: Kotańska, Magdalena, et al.
Publicado: (2017)

Structural basis of ligand recognition in 5-HT(3) receptors
por: Kesters, Divya, et al.
Publicado: (2013)

Synthesis, antitumor activity, 3D-QSAR and molecular docking studies of new iodinated 4-(3H)-quinazolinones 3N-substituted
por: Pérez-Fehrmann, Marcia, et al.
Publicado: (2022)

Dibenzazecine compounds with a novel dopamine/5HT(2A )receptor profile and 3D-QSAR analysis
por: Hamacher, Alexandra, et al.
Publicado: (2006)

Dibenzofuranylethylamines as 5-HT(2A/2C) Receptor Agonists
por: Yempala, Thirumal, et al.
Publicado: (2020)

Translating the promise of 5HT(4) receptor agonists for the treatment of depression
por: Murphy, Susannah E, et al.
Publicado: (2021)

Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms
por: Huang, Xuefei, et al.
Publicado: (2017)

5-Fluorotryptamine is a partial agonist at 5-HT(3) receptors, and reveals that size and electronegativity at the 5 position of tryptamine are critical for efficient receptor function
por: Bower, Kiowa S., et al.
Publicado: (2008)

CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
por: Capi, Matilde, et al.
Publicado: (2021)

Effect of Selective 5-HT6R Agonist on Expression of 5-HT Receptor and Neurotransmitter in Vascular Dementia Rats
por: Yu, Haining, et al.
Publicado: (2017)

Alignment independent 3D-QSAR studies and molecular dynamics simulations for the identification of potent and selective S1P(1) receptor agonists
por: Alizadeh, Ali Akbar, et al.
Publicado: (2020)

Searching for the Molecular Basis of Partial Deafness
por: Oziębło, Dominika, et al.
Publicado: (2022)

Study on the effect of EMD386088, a 5-HT(6) receptor partial agonist, in enhancing the anti-immobility action of some antidepressants in rats
por: Jastrzębska-Więsek, Magdalena, et al.
Publicado: (2017)

Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013)

A single channel mutation alters agonist efficacy at 5-HT(3)A and 5-HT(3)AB receptors
por: Thompson, A J, et al.
Publicado: (2013)

Nicotine receptor partial agonists for smoking cessation
por: Livingstone-Banks, Jonathan, et al.
Publicado: (2023)

Nicotine receptor partial agonists for smoking cessation
por: Livingstone-Banks, Jonathan, et al.
Publicado: (2023)

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case series
por: Okita, Kyoji, et al.
Publicado: (2013)

Pharmacokinetics of DA-6886, A New 5-HT(4) Receptor Agonist, in Rats
por: Lee, Dae Young, et al.
Publicado: (2022)

5-HT(2) and 5-HT(7) receptor agonists facilitate plantar stepping in chronic spinal rats through actions on different populations of spinal neurons
por: Sławińska, Urszula, et al.
Publicado: (2014)

Kinetic basis of partial agonism at NMDA receptors
por: Kussius, Cassandra L, et al.
Publicado: (2009)

Application of Synchrotron Radiation-Based Fourier-Transform Infrared Microspectroscopy for Thermal Imaging of Polymer Thin Films
por: Chavez-Angel, Emigdio, et al.
Publicado: (2023)

New MT(2) Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists
por: Boutin, Jean A., et al.
Publicado: (2017)

Do AutoML-Based QSAR Models Fulfill OECD Principles for Regulatory Assessment? A 5-HT(1A) Receptor Case
por: Czub, Natalia, et al.
Publicado: (2022)

Tandospirone, a Partial 5-HT(1A) Receptor Agonist, Administered Systemically or Into Anterior Cingulate Attenuates Repetitive Behaviors in Shank3B Mice
por: Dunn, Jeffrey T, et al.
Publicado: (2020)

Effect of 5-HT(1A) Receptor Partial Agonists of the Azapirone Class as an Add-On Therapy on Psychopathology and Cognition in Schizophrenia: A Systematic Review and Meta-Analysis
por: Yamada, Risa, et al.
Publicado: (2023)

Novel glitazones as PPARγ agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies
por: Mandal, Subhankar P., et al.
Publicado: (2018)

Discovery of new TLR7 agonists by a combination of statistical learning-based QSAR, virtual screening, and molecular dynamics
por: Abiri, Ardavan, et al.
Publicado: (2021)

Enhancement by Hydrogen Peroxide of Calcium Signals in Endothelial Cells Induced by 5-HT1B and 5-HT2B Receptor Agonists
por: Avdonin, Pavel V., et al.
Publicado: (2019)

A New Approach to Radial Basis Function Approximation and Its Application to QSAR
por: Zakharov, Alexey V., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l9o72r7p48k0q2r0te2qhf3jva